1. Home
  2. PCRX vs UTI Comparison

PCRX vs UTI Comparison

Compare PCRX & UTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • UTI
  • Stock Information
  • Founded
  • PCRX 2006
  • UTI 1965
  • Country
  • PCRX United States
  • UTI United States
  • Employees
  • PCRX N/A
  • UTI N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • UTI Other Consumer Services
  • Sector
  • PCRX Health Care
  • UTI Real Estate
  • Exchange
  • PCRX Nasdaq
  • UTI Nasdaq
  • Market Cap
  • PCRX 1.2B
  • UTI 1.4B
  • IPO Year
  • PCRX 2011
  • UTI 2003
  • Fundamental
  • Price
  • PCRX $25.16
  • UTI $26.52
  • Analyst Decision
  • PCRX Buy
  • UTI Strong Buy
  • Analyst Count
  • PCRX 9
  • UTI 6
  • Target Price
  • PCRX $26.22
  • UTI $31.17
  • AVG Volume (30 Days)
  • PCRX 805.4K
  • UTI 733.4K
  • Earning Date
  • PCRX 02-27-2025
  • UTI 02-05-2025
  • Dividend Yield
  • PCRX N/A
  • UTI N/A
  • EPS Growth
  • PCRX N/A
  • UTI 238.05
  • EPS
  • PCRX N/A
  • UTI 0.97
  • Revenue
  • PCRX $694,957,000.00
  • UTI $759,421,000.00
  • Revenue This Year
  • PCRX $5.55
  • UTI $12.22
  • Revenue Next Year
  • PCRX $5.64
  • UTI $8.42
  • P/E Ratio
  • PCRX N/A
  • UTI $27.19
  • Revenue Growth
  • PCRX 4.40
  • UTI 14.70
  • 52 Week Low
  • PCRX $11.16
  • UTI $13.66
  • 52 Week High
  • PCRX $31.67
  • UTI $30.56
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 52.48
  • UTI 44.61
  • Support Level
  • PCRX $25.41
  • UTI $26.78
  • Resistance Level
  • PCRX $26.89
  • UTI $29.28
  • Average True Range (ATR)
  • PCRX 1.18
  • UTI 1.42
  • MACD
  • PCRX -0.36
  • UTI -0.17
  • Stochastic Oscillator
  • PCRX 4.35
  • UTI 6.91

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About UTI Universal Technical Institute Inc

Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields. The company's reportable segment which includes Universal Technical Institute (UTI) and Concorde Career Colleges, Corporate. Majority of the revenue is generated from UTI segment which provides different kinds of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and others. It also provides dealer technician training or instructor staffing services to manufacturers.

Share on Social Networks: